BAM
TECH icon

Bullseye Asset Management’s Bio-Techne TECH Stock Holding History

Bullseye Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-31,104
Closed -$2.97M – 102
2021
Q1 		$2.97M Hold
31,104
– – 1.11% 41
2020
Q4 		$2.47M Sell
31,104
-572
-2% -$41.4K 0.92% 40
2020
Q3 		$1.96M Sell
31,676
-44
-0.1% -$2.86K 0.89% 45
2020
Q2 		$2.09M Buy
31,720
+1,288
+4% +$77.1K 1.12% 35
2020
Q1 		$1.44M Sell
30,432
-172
-0.6% -$8.6K 1.72% 22
2019
Q4 		$1.68M Buy
+30,604
New +$1.61M 1.62% 25

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bullseye Asset Management's TECH Position: Q2 2021 in Review

Bullseye Asset Management sold out of Bio-Techne (TECH) in Q2 2021, closing a stake of 31,104 shares — an estimated $2.97M sold.

Bullseye Asset Management first reported a position in TECH in Q4 2019 and held it in 6 quarters. The position peaked at $2.97M in Q1 2021. 513 funds tracked by Wall St. Rank hold TECH as of Q2 2021.

  • Bullseye Asset Management reported no remaining Bio-Techne position as of Q2 2021 after selling out during the quarter.
  • Bullseye Asset Management sold 31,104 Bio-Techne shares in Q2 2021, an estimated $2.97M.
  • Bullseye Asset Management first reported a position in Bio-Techne in Q4 2019 and held it in 6 quarters.
  • Bullseye Asset Management's Bio-Techne position peaked at $2.97M in Q1 2021.
  • 513 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2021.

Based on Bullseye Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.